Bufferin



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 13.7%
Hypertension 12.3%
Pain 11.4%
Headache 10.5%
Cardiac Disorder 8.2%
Migraine 6.4%
Diabetes Mellitus 4.6%
Antiphospholipid Syndrome 3.7%
Anticoagulant Therapy 3.2%
Arthritis 3.2%
Blood Pressure 3.2%
Cardiovascular Disorder 2.7%
Thrombosis 2.7%
Blood Cholesterol 2.3%
Blood Disorder 2.3%
Rheumatoid Arthritis 2.3%
Asthma 1.8%
Back Pain 1.8%
Depression 1.8%
In Vitro Fertilisation 1.8%
Incorrect Drug Administration Duration 15.7%
Death 8.6%
Respiratory Tract Infection 8.6%
Diabetes Mellitus 5.7%
Drug Dependence 5.7%
Asthma 4.3%
Infarction 4.3%
Myocardial Infarction 4.3%
Placenta Praevia 4.3%
Premature Labour 4.3%
Stevens-johnson Syndrome 4.3%
Syncope 4.3%
Tachycardia 4.3%
Vomiting 4.3%
Breast Cancer 2.9%
Dementia Alzheimer's Type 2.9%
Haemorrhage 2.9%
Premature Separation Of Placenta 2.9%
Road Traffic Accident 2.9%
Sinusitis 2.9%
Secondary
Hypertension 20.2%
Rheumatoid Arthritis 11.4%
Myocardial Infarction 9.7%
Cerebral Infarction 5.4%
Product Used For Unknown Indication 5.1%
Thrombosis Prophylaxis 5.1%
Gastritis 4.4%
Hyperlipidaemia 4.4%
Pain 4.1%
Diabetes Mellitus 3.4%
Benign Prostatic Hyperplasia 3.3%
Cardiac Failure Chronic 3.1%
Angina Pectoris 2.8%
Atrial Fibrillation 2.7%
Hyperuricaemia 2.7%
Drug Use For Unknown Indication 2.6%
Osteoporosis 2.6%
Headache 2.4%
Prophylaxis 2.4%
Chronic Obstructive Pulmonary Disease 2.1%
Melaena 16.9%
Interstitial Lung Disease 8.9%
Temporal Lobe Epilepsy 8.1%
Liver Disorder 6.5%
Pneumonia 5.6%
Small Intestinal Haemorrhage 5.6%
Toxic Epidermal Necrolysis 5.6%
White Blood Cell Count Increased 4.8%
Hepatic Function Abnormal 4.0%
Pyrexia 4.0%
Stevens-johnson Syndrome 4.0%
Syncope 4.0%
Drug Dependence 3.2%
Road Traffic Accident 3.2%
Sudden Cardiac Death 3.2%
White Blood Cell Count Decreased 3.2%
Incorrect Drug Administration Duration 2.4%
Status Epilepticus 2.4%
Subdural Haematoma 2.4%
Agranulocytosis 1.6%
Concomitant
Hypertension 26.8%
Angina Pectoris 8.4%
Drug Use For Unknown Indication 7.4%
Prophylaxis 6.6%
Product Used For Unknown Indication 5.2%
Rheumatoid Arthritis 4.6%
Constipation 4.1%
Insomnia 4.1%
Diabetes Mellitus 4.0%
Cerebral Infarction 3.6%
Hyperlipidaemia 3.4%
Osteoporosis 3.0%
Gastritis 2.9%
Atrial Fibrillation 2.7%
Myocardial Infarction 2.5%
Multiple Myeloma 2.4%
Type 2 Diabetes Mellitus 2.2%
Depression 2.1%
Cardiac Failure 2.1%
Hiv Infection 1.9%
Vomiting 10.5%
Pneumonia 8.4%
Thrombocytopenia 7.5%
Renal Impairment 6.9%
Hyponatraemia 5.7%
Hepatic Function Abnormal 5.4%
White Blood Cell Count Decreased 5.4%
Respiratory Failure 5.1%
White Blood Cell Count Increased 4.8%
Malaise 4.2%
Weight Decreased 4.2%
Interstitial Lung Disease 3.9%
Pyrexia 3.9%
Sepsis 3.9%
Death 3.6%
Hypoglycaemia 3.6%
Inappropriate Antidiuretic Hormone Secretion 3.3%
Renal Failure Acute 3.3%
Cardiac Failure 3.0%
Diarrhoea 3.0%